Back
EHRA Premium Access

Does the presence and indication of cardiac device influence the outcome of radiofrequency pulmonary vein isolation for atrial fibrillation?

Session: Poster session 2 - Atrial Fibrillation - Treatment
Topic: Rhythm Control, Catheter Ablation
Speaker: Doctor P. Purnode (Brussels, BE)
Event: EHRA 2019

Congress Presentation

About the speaker

Doctor Philippe Purnode

Clinique Saint-Jean, Brussels (Belgium)
0 follower

61 more presentations in this session

Mapping persistent atrial fibrillation with a high-density grid-style catheter: procedural characteristics and ablation lesion distribution

Speaker: Professor P. Gora (Bad Oeynhausen, DE)

Access
Abstract
Slides
Thumbnail

Distribution of reablated antral segments after initial pulmonary vein isolation with use of ablation index.

Speaker: Associate Professor K. Neven (Essen, DE)

Access
Abstract
Slides
Thumbnail

One-year clinical outcome after pulmonary vein isolation with use of ablation index in patients with persistent atrial fibrillation.

Speaker: Professor N. Reinsch (Essen, DE)

Access
Abstract
Slides
Thumbnail

Safety and feasibility of a minimally fluoroscopic approach during pulmonary vein isolation for atrial fibrillation.

Speaker: Professor N. Reinsch (Essen, DE)

Access
Abstract
Slides
Thumbnail

Safety and feasibility of pulmonary vein isolation for atrial fibrillation in morbidly obese patients with a body mass index of more than 40 kg/m2.

Speaker: Professor N. Reinsch (Essen, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster session 2 - Atrial Fibrillation - Treatment

Speakers: Doctor P. Purnode, Professor P. Gora, Associate Professor K. Neven, Professor N. Reinsch, Professor N. Reinsch...
Access
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb